Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis

Down-regulating circular RNA_0004674 delays the progression of oral squamous cell carcinoma through microRNA-377-3p/THBS1 axis

(2021) Xue Zhang et al.   LIFE SCIENCES

Progress of non-coding RNAs in triple-negative breast cancer

(2021) Jie Liu et al.   LIFE SCIENCES

Doxorubicin-induced novel circRNA_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating MCL1 through miR-142-5p

(2021) Xiao-Long Ma et al.   Cell Death Discovery

HIF2-Induced Long Noncoding RNA RAB11B-AS1 Promotes Hypoxia-Mediated Angiogenesis and Breast Cancer Metastasis

(2020) Yanling Niu et al.   CANCER RESEARCH

Regulatory Mechanism of MicroRNA Expression in Cancer

(2020) Zainab Ali Syeda et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

High levels of chromosomal copy number alterations and TP53 mutations correlate with poor outcome in younger breast cancer patients

(2020) Ayla Koçak et al.   AMERICAN JOURNAL OF PATHOLOGY

LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway

(2020) Yang Li et al.   Cancer Cell International

MiR-377-3p suppresses colorectal cancer through negative regulation on Wnt/β-catenin signaling by targeting XIAP and ZEB2

(2020) Lifeng Huang et al.   PHARMACOLOGICAL RESEARCH

The Novel Circular RNA Circ-PGAP3 Promotes the Proliferation and Invasion of Triple Negative Breast Cancer by Regulating the miR-330-3p/Myc Axis

(2020) Dabao He et al.   OncoTargets and Therapy

STAT3 and p53: Dual Target for Cancer Therapy

(2020) Thu-Huyen Pham et al.   Biomedicines

Extracellular Adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A3 Adenosine Receptor activation under Hypoxia

(2019) Ángelo Torres et al.   CANCER LETTERS

Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway

(2019) Xiaolong Wang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The Landscape of Circular RNA in Cancer

(2019) Josh N. Vo et al.   CELL

Widespread and Functional RNA Circularization in Localized Prostate Cancer

(2019) Sujun Chen et al.   CELL

EBF1-mediated upregulation of ribosome assembly factor PNO1 contributes to cancer progression by negatively regulating the p53 signaling pathway

(2019) Aling Shen et al.   CANCER RESEARCH

Beyond the seed: structural basis for supplementary microRNA targeting by human Argonaute2

(2019) Jessica Sheu‐Gruttadauria et al.   EMBO JOURNAL

MicroRNA-377-3p inhibits growth and invasion through sponging JAG1 in ovarian cancer

(2019) Liulin Tang et al.   Genes & Genomics

Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer

(2019) Cheng-Cao Sun et al.   MOLECULAR THERAPY

Intratumour heterogeneity of p53 expression; causes and consequences

(2019) Yuezhen Xue et al.   JOURNAL OF PATHOLOGY

Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis

(2019) Max D. Wellenstein et al.   NATURE

Mutant p53 improves cancer cells’ resistance to endoplasmic reticulum stress by sustaining activation of the UPR regulator ATF6

(2019) Daria Sicari et al.   ONCOGENE

The biogenesis, biology and characterization of circular RNAs

(2019) Lasse S. Kristensen et al.   NATURE REVIEWS GENETICS

m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis

(2019) Dan Jin et al.   Journal of Hematology & Oncology

Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to Treatment

(2018) Nicolo Riggi et al.   Annual Review of Pathology-Mechanisms of Disease

Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for non-small cell lung cancer

(2018) Shuangyan Tan et al.   CELL RESEARCH

p53 Mediates Vast Gene Expression Changes That Contribute to Poor Chemotherapeutic Response in a Mouse Model of Breast Cancer

(2018) Crystal Tonnessen-Murray et al.   Translational Oncology

circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression

(2018) Bo Chen et al.   Theranostics

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Screening circular RNA related to chemotherapeutic resistance in osteosarcoma by RNA sequencing

(2018) Zhu Kun-Peng et al.   Epigenomics

NFIB promotes cell survival by directly suppressing p21 transcription in TP53 -mutated triple-negative breast cancer

(2018) Rong-Zong Liu et al.   JOURNAL OF PATHOLOGY

P53 in kidney injury and repair: Mechanism and therapeutic potentials

(2018) Chengyuan Tang et al.   PHARMACOLOGY & THERAPEUTICS

circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a

(2017) Rongfang He et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Molecular alterations in triple-negative breast cancer—the road to new treatment strategies

(2017) Carsten Denkert et al.   LANCET

Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer

(2017) Ana C. Gregório et al.   PATHOLOGY & ONCOLOGY RESEARCH

A functional polymorphism inlnc-LAMC2-1:1confers risk of colorectal cancer by affecting miRNA binding

(2016) Jing Gong et al.   CARCINOGENESIS

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

(2016) Giampaolo Bianchini et al.   Nature Reviews Clinical Oncology

Biology and Management of Patients With Triple-Negative Breast Cancer

(2016) P. Sharma   ONCOLOGIST

miRNA Deregulation in Cancer Cells and the Tumor Microenvironment

(2016) R. Rupaimoole et al.   Cancer Discovery

The RNA Binding Protein Quaking Regulates Formation of circRNAs

(2015) Simon J. Conn et al.   CELL

AKT mediates actinomycin D-induced p53 expression

(2015) Chih-Shou Chen et al.   Oncotarget

Correlation of circular RNA abundance with proliferation – exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis and normal human tissues

(2015) Anna Bachmayr-Heyda et al.   Scientific Reports

miR-185 Suppresses Tumor Proliferation by Directly Targeting E2F6 and DNMT1 and Indirectly Upregulating BRCA1 in Triple-Negative Breast Cancer

(2014) H. Tang et al.   MOLECULAR CANCER THERAPEUTICS

MicroRNAs in Cancer

(2013) Gianpiero Di Leva et al.   Annual Review of Pathology-Mechanisms of Disease

MicroRNA-33a Mediates the Regulation of High Mobility Group AT-Hook 2 Gene (HMGA2) by Thyroid Transcription Factor 1 (TTF-1/NKX2–1)

(2013) Shawn J. Rice et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Circular RNAs are a large class of animal RNAs with regulatory potency

(2013) Sebastian Memczak et al.   NATURE

Triple-negative breast cancer: epidemiological considerations and recommendations

(2012) P. Boyle   ANNALS OF ONCOLOGY

Developments in Ki67 and other biomarkers for treatment decision making in breast cancer

(2012) A. Sheri et al.   ANNALS OF ONCOLOGY

Tumor Suppression by p53: Fall of the Triumvirate?

(2012) Andreas K. Hock et al.   CELL

Pno1 Tissue-Specific Expression and Its Functions Related to the Immune Responses and Proteasome Activities

(2012) Xuehai Wang et al.   PLoS One

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

(2011) Elisabeth Luporsi et al.   BREAST CANCER RESEARCH AND TREATMENT